Changes in Plaque Volume and Plaque Composition After 12 Weeks of Extensive LDL-C Reduction With PCSK9 Inhibitors in ACS Patients With Multivessel Disease
Presenter:
We Recommend
Disclosures
Nothing to disclose
New at TCTMD? Register today!
Enter the email you used to register to reset your password.